ArticleCardiovascular drugs and therapy2025

Hyperoside Protects Trastuzumab-Induced Cardiotoxicity via Activating the PI3K/Akt Signaling Pathway.

Shanshan Wei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.